Role of complement in the aetiology of Pick's disease?

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 5, 1996, Pages 578-593

  Singhrao, S K ^a   Neal, J W ^a   Gasque, P ^a   Morgan, B P ^a   Newman, G R ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Astrocytes; Classical pathway; Complement; Immunocytochemistry; Neurons; Pick's disease

Indexed keywords

CD59 ANTIGEN; COMPLEMENT; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C6; COMPLEMENT COMPONENT C8; COMPLEMENT MEMBRANE ATTACK COMPLEX; DECAY ACCELERATING FACTOR; MEMBRANE COFACTOR PROTEIN;

ARTICLE; AUTOPSY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOELECTRON MICROSCOPY; IMMUNOPATHOGENESIS; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL;

EID: 0029873037     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199605000-00010     Document Type: Article

References (26)

1. Pick A. Ueber einen weiteren symptomenkomplex im rahmen der dementia senilis, bedingt durch umschriebene starkere hirnatrophie (gemischte apraxie) Pshchiatrie und Neurologie 1906;19:97-108
2. Constantinidis J, Richard J, Tissot R. Pick's disease. Histological and clinical correlations. Eur Neurol 1974;11:208-17
3. Joachim CL, Morris JH, Kosik KS, Selkoe DJ. Tau antisera recognise neurofibrillary tangles in a range of neurodegenerative disorders. Ann Neurol 1987;514-20
4. Love S, Saitoh T, Quijada S, Cole GM, Terry RD. Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies. J Neuropathol Exp Neurol 1988;47:393-405
5. Murayama S, Mori H, Ihara Y, Tomonaga M, Immunocytochemical and ultrastructural studies of Pick's disease. Ann Neurol 1990;27: 394-405
6. Kato S, Nakamura H. Presence of two different fibril subtypes in the Pick body: An immunoelectron microscopic study. Acta Neuropathol (Berl) 1990;81:125-29
7. Yasuhara O, Yoshinari A, McGeer E, McGeer PL. Expression of the complement membrane attack complex and its inhibitors in Pick disease brain. Brain Res 1994;652:346-49
8. Singhrao S, Cole G, Henderson WJ, Newman GR. LR White allows a multi-method approach to the analysis of brain tissue from patients with Alzheimer's disease. Histochem J 1990;22:257-68
9. Newman GR, Hobot JA. Resin microscopy and on-section immunocytochemistry. Heidelberg, Springer-Verlag, 1993
10. Reynolds ES. The use of lead citrate at high pH as an electron opaque stain in the electron microscope. J Cell Biol 1963;17:208
11. Ishii T, Haga S, Shimizu F. Identification of components of immunoglobulins in senile plaques by means of fluorescent antibody technique. Acta Neuropathol (Berlin) 1975;32:157-62
12. Ishii T, Haga S, Immunoelectro microscopic localization of immunoglobulins in amyloid fibrils of senile plaques. Acta Neuropathol (Berlin) 1976;36:243-49
13. Powers JM, Schlaepfer WW, Willingham ML, Hall BJ. An immunoperoxidase study of senile cerebral amyloidosis with pathogenetic considerations. J Neuropathol Exp Neurol 1891;40:592-612
14. Gasque P, Julen N, Ischenko A, Picot C, Mauger C, Chauzy C, Ripochc J, Fontaine M. Expression of complement components of the alternative pathway by glioma cell lines. J Immunol 1992;149: 1381-87
15. Gasque P, Ischenko A, Legoedec J, Mauger C. Schouft MT, Fontaine M. Expression of the complement classical pathway by human glioma in culture. J Biol Chem 1993;268:25068-74
16. Gasque P, Fontaine M, Morgan P. Complement expression in human brain: Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines. J Immunol 1995;154:4726-33
17. Gasque P, Thomas A, Fontaine M, Morgan P. Complement activation on neurons in vitro: Route of activation and expression of functional complement regulatory proteins. J Neuroimmunol (in press)
18. Morgan BP. Complement membrane attack on nucleated cells: Resistance, recovery and non-lethal effects. Biochem J 1989;264.1-14
19. McGeer PL, Akiyama H, Itagaki S, McGeer EG. Activation of the classical complement pathway in brain tissue of Alzheimer patients Neurosci Lett 1989a;107:341-46
20. McGeer PL, Akiyama H, Itagaki S, McGeer EG. Immune system response in Alzheimer's disease Can J Neurol Sci 1989b;16:516-27
21. Rogers J, Cooper NR, Webster S, Schulz J, McGeer PL, Styren SD, Civin WH, Brachova L, Bradt B, Ward P. Lieberburg I. Complement activation by beta-amyloid in Alzheimer disease. Proc Natl Acad Sci USA 1992;89:10016-20
22. Morgan BP, Sewry CA, Siddle K, Luzio JP, Campbell AK. Immunolocalisation of complement component C9 on necrotic and non-necrotic muscle fibres in myositis using monoclonal antibodies. Immunology 1984;181-88
23. Kemp PA, Spragg JH, Brown JC, Morgan BP, Gunn C, Taylor PW. Immunohistochemical determination of complement activation in joint tissues of patients with rheumatoid arthritis and osteoarthritis using neoantigen-specific monoclonal antibodies. J Clin Lab Immunol 1992;37:147-62
24. Singhrao SK, Morgan BP, Neal JW, Newman GR. A Functional role for corpora amylacea based on evidence from complement studies. Neurodegeneration 1995;4:335-45
25. May PC, Finch CE. Sulfated glycoprotein 2: New relationships of this multifunctional protein to neurodegeneration. Trend Neurosci 1992;15:391-96
26. Rozovsky I, Morgan TE, Willoughby DA, Dugichi-Djodjevich MM, Pasinetti GM, Johnson SA, Finch CE. Selective expression of clusterin (SGP-2) and complement C1qB and C4 during responses to neurotoxins in vivo and in vitro. Neuroscience 1994;62:741-58